NCT06952179 is a clinical trial in Inflammatory Response, sponsored by Samsun University.

Who is sponsoring NCT06952179?

NCT06952179 is sponsored by Samsun University.

What condition does NCT06952179 study?

NCT06952179 studies Inflammatory Response, COVID-19, Pericardial Disease.

Is NCT06952179 still recruiting?

NCT06952179 is currently completed. Last updated 30 April 2025.

Last reviewed 2025-04-30 · How we verify

NCT06952179

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pericardial Histopathology and COVID-19 Seropositivity

Completed Last updated 30 April 2025

What this trial tests

trial in Inflammatory Response in 93 participants. Completed in 1 June 2024.

Timeline

1 February 2023

Primary endpoint
1 February 2024

1 June 2024

Quick facts

Lead sponsor	Samsun University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	93
Start date	1 February 2023
Primary completion	1 February 2024
Estimated completion	1 June 2024
Sites	1 location across Turkey (Türkiye)

Conditions studied

Inflammatory Response — all drugs for Inflammatory Response →
COVID-19 — all drugs for COVID-19 →
Pericardial Disease — all drugs for Pericardial Disease →

Sponsor

Samsun University

Who can join

Adults 20 to 75, any sex, with Inflammatory Response or COVID-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective study aims to investigate the association between pericardial histopathologic inflammation grades (acute, chronic, or absent) and COVID-19 seropositivity in adult patients undergoing first-time isolated coronary artery bypass grafting (CABG). Pericardial tissue samples were collected during surgery and evaluated histopathologically, while preoperative COVID-19 serological testing was performed. The primary outcome is to determine whether COVID-19 seropositivity is associated with the severity of pericardial inflammation. Patients with prior cardiac surgery, active COVID-19 infection, systemic inflammatory diseases, chronic immunosuppressive therapy, or malignancy were excluded from the study.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Histopathological Evaluation of the Pericardium in CABG Patients With and Without Prior SARS-CoV-2 Infection: A Prospective Observational Study.
Ereren E, Ağırbaş H, Karal İH, Koç Şahin S, et al · · 2025 · PMID 41466119 · DOI 10.12659/msm.950106

Verify or expand the search:

Other recruiting trials for Inflammatory Response

Currently open trials in the same condition.

NCT06450704 — Cerebral and Anti-inflammatory Response Through Exercise - Mechanisms In Depressive Disorders · NA · recruiting
NCT06519487 — Social Experiences and Demographic Factors in the Regulation of Immune Cells · NA · recruiting
NCT06434701 — Severe COVID-19 Infection in Children Presenting to EDs in Israel and England · NA · recruiting
NCT06491966 — Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis · recruiting
NCT06342024 — Pistachio Consumption on Inflammatory Markers and Lean Body Mass · NA · active not recruiting

Other Samsun University trials

Trials by the same sponsor.

NCT07418476 — Comparison of Standard ACL Reconstruction Versus TARS-Augmented Reconstruction · NA · recruiting
NCT07348419 — Quadro-Iliac vs Thoracolumbar Interfascial Plane Block for Analgesia After Single-Level Lumbar Disc Surgery · NA · recruiting
NCT07372846 — BRI, BMI, and VIDAC Score Relationship in Obese Patients · recruiting
NCT07260396 — Comparison of Sensory Block Coverage and Clinical Effectiveness of TAP and Rectus Sheath Blocks in Pfannenstiel Incision · not yet recruiting
NCT07348523 — Comparison of the Postoperative Analgesic Efficacy of Classical and Modified Erector Spinae Plane Blocks After Lumbar Sp · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06952179 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Samsun University
Last refreshed: 30 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06952179.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing